Tryptase as a Biomarker for Adverse Prognosis in ST-Segment Elevation Myocardial Infarction Patients: A Prospective Cohort Study

Tryptase as a Biomarker for Adverse Prognosis in ST-Segment Elevation Myocardial Infarction Patients: A Prospective Cohort Study

Pengxin Xie,1,2 Shuwan Xu,1,2 Xi Chen,1,2 Hong Xu,3 Ruitao Zhang,1,2 Dan Li,1,2 Lijie Sun,1,2 Dan Zhu,1,2 Ming Cui1,2 1Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, People’s Republic of China; 2State Key Laboratory of Vascular Homeostasis and...

Full description

Saved in:
Bibliographic Details
Main Authors: Xie P, Xu S, Chen X, Xu H, Zhang R, Li D, Sun L, Zhu D, Cui M
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Journal of Inflammation Research
Subjects:
acute st-segment elevation myocardial infarction
mast cells
tryptase
major adverse cardiovascular events
prognosis.
Online Access:https://www.dovepress.com/tryptase-as-a-biomarker-for-adverse-prognosis-in-st-segment-elevation--peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/tryptase-as-a-biomarker-for-adverse-prognosis-in-st-segment-elevation--peer-reviewed-fulltext-article-JIR

Similar Items